Comparative Efficacy of Etiotropic Therapy of Patients with HBeAg-Positive Chronic Hepatitis B (by the Data of the International Comparative Placebo-Controlled Study)

Comparative placebo-controlled study entrolled 647 patients with verified diagnosis of chronic virus hepatitis B (HBeAg+), not previously subjected to antiviral therapy (with nucleotide analogues or interferons). The drug under the investigation was cycloferon, an earlier interferon inductor. The an...

ver descrição completa

Detalhes bibliográficos

Principais autores:	V. V. Stelmakh, M. G. Romantsov, T. V. Sologub, A. A. Shuldyakov, V. K. Kozlov, N. Kh. Tuan, M. .. Ovungerel, V. M. Frolov
Formato:	Artigo
Idioma:	Russo
Publicado em:	LLC "Publishing House OKI" 2020-05-01
coleção:	Антибиотики и Химиотерапия
Assuntos:	hbv hbeag+ chronic virus hepatitis b interferon inductor antivirals lamivudine cycloferon
Acesso em linha:	https://www.antibiotics-chemotherapy.ru/jour/article/view/507
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!